Grant

BIOTRONIK - Conduction System Pacing with the Solia Lead

Abstract

The purpose of the BIO-CONDUCT study is to demonstrate the safety and effectiveness of the BIOTRONIK Solia S pacing lead when implanted in the left bundle branch (LBB) area. Safety will be assessed by evaluating serious adverse device effects that occur through 3 months post-implant. Efficacy will be assessed by evaluating implant success rate.

People

Raeven Maxwell
(CD)
COM Phx Internal Medicine﹒Clinical Research Coordinator II
Mathew Freeman
(CD)
COM Phx Internal Medicine﹒Clinical Research Coordinator IV
Roderick Tung
Principal Investigator (PI)
COM Phx Internal Medicine﹒Chief
Elena Young
(CD)
COM Phx Internal Medicine﹒Research Compliance Manager II
Mason Burchfield
(CD)
COM Phx Internal Medicine﹒Research Compliance Administrator III
Michael Zawaneh
Co-Investigator (COI)
COM Phx Internal Medicine﹒Assistant Clinical Professor, Internal Medicine
Wilber Su
Co-Investigator (COI)
COM Phx Internal Medicine﹒Clinical Professor, Internal Medicine

Grant

Grant

BIOTRONIK - Conduction System Pacing with the Solia Lead

Sponsored by Biotronik, Inc.

Related Topics

Abstract

People

Raeven Maxwell

Mathew Freeman

Roderick Tung

Elena Young

Mason Burchfield

Michael Zawaneh

Wilber Su